All the Therapeutic System Drugs
Somatropin Agonist. Somatotrophin 5.3 mg, 12 mg. TWO CHAMBER CARTRIDGES: U2-pen: 1 x 5.3 mg/ml, 12 mg/ml.
Pre-Filled Pen (Go Quick): 1 x 5.3 mg/ml, 12 mg/ml.
Dosage must be ajust. individ.
Child. Short stature due to inadeq. or fail.
secret. of pituit. growth horm. or Turner’s
synd.. Short stature in child. with chron.
Growth disturb. (height SDS< -2.5 and
parent. adjust. height SDS< -1) in short
child. born SGA (SGA – small for gestat.
age, i.e. born small in relation to the
length of the fetus develop. ), with a birth
wt. and/or length < -2 SD, who fail. to
show catch up growth (HV SDS <0 during
the last year) by 4 yrs. of age or later. In
Prader-Willi syndr. (PWS) to improve
growth and body composit. The diagnosis of PWS should be confirm.
by genetic analysis.
Adult.: Adult. with Growth-hormone
defic. since childhood.
Adult. who have acquir. growth hormone
defic. due to a pituit. pathology causing
Any eviden. of activity of a tumour.
Intracran. tumour. must be inactive and
antitumour ther. must be complet. prior
to init. growth hormone. ther. Tmt.
should be discount. if there is evidence
of tumour growth.
Growth promot. in child. with closed
Pts. with acute critical illness suffer.
complic. follow. open heart surg.,
abdom. surg., multiple accident. trauma,
acute respire. fail. or similar condit.
should not be treated with Genotropin
(regard. pts. underg. substitut. ther.
Pts. with Prader-Willi syndr. who are
sever. obese or have severe respirat.
impair. Pts. with active prolifer. or severe nonprolifer. diabetic retinop.